1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Aegle Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MSC EVs in Dystrophic Epidermolysis Bullosa AGLE-102 - Dystrophic Epidermolysis Bullosa | Phase 1 / Phase 2 | Recruiting | Aegle Therapeutics | 8 | 2024-08-13 | 2025-06-25 |
| Safety of Extracellular Vesicles for Burn Wounds AGLE-102 - Burns | Phase 1 | Completed | Aegle Therapeutics | 1 | 2023-08-10 | 2024-11-20 |
Burns (1) · Epidermolysis Bullosa Dystrophica (1)
United States (2)
Carl Schulman, MD (1) · David T Woodley, MD (1)